VSIG4 interaction with heparan sulfates inhibits VSIG4–complement binding
Sarah Ebstein(Regeneron (United States)), Dimitris Skokos(Regeneron (United States)), Ashique Rafique(Regeneron (United States)), Tammy Huang(Regeneron (United States)), Amanda Krasco(Regeneron (United States)), William C. Olson(Regeneron (United States)), Benjamin J. Daniel(Regeneron (United States)), Aynur Hermann(Regeneron (United States)), Welby Montalvo-Ortiz(Regeneron (United States)), Sebastien Coquery(Regeneron (United States)), Joyce Wei(Regeneron (United States)), Matthew A. Sleeman(Aimmune Therapeutics (United Kingdom)), Erica Ullman(Regeneron (United States)), Nicolin Bloch(Regeneron (United States)), Ken-Wing Lee(Regeneron (United States)), Funmilola Adewale(Regeneron (United States)), Yi Zhou(Kanazawa University), Lola Yu(Regeneron (United States)), Dominic Vergata(Regeneron (United States)), Luisaidy Custodio(Regeneron (United States)), Andrew Murphy(DePaul University), Rene C. Adam(Western Sydney University), Samuel Davis(Regeneron (United States)), Antonio N. Luz(Regeneron (United States)), Matthew C. Franklin(Regeneron (United States))
Cited by 5
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
VEGF-Trap: A VEGF blocker with potent antitumor effects
|Proceedings of the National Academy of Sciences|2002|1.7k
Regulation of the Germinal Center Response by MicroRNA-155
|Science|2007|1.5k